Lupus Nephritis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies

Retrieved on: 2022-12-14 16:10:09

Tags for this article:

Click the tags to see associated articles and topics

Lupus Nephritis Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies. View article details on hiswai:

Excerpt

Ravulizumab: Alexion Pharmaceuticals • Anifrolumab: AstraZeneca • Itolizumab: Equillium. Lupus Nephritis Market Dynamics

Article found on: www.digitaljournal.com